Emerging-Biotech Open to everyone

Loading Portfolio...
Loading...

id	rsymbol	Symbol	Current Price	Change (%)	Open	High	Low	Volume	Date Added	Cost per share	Quantity	Value Weighting	Gain (%)	Fair Value ($)	Note	Company	Exchange	Industry	Market Cap ($M)	Sales ($M)	Book Value	Debt to Equity	Yield	Payout	Financial Strength	Profitability	Interest Coverage	52-W Range	1-W Change (%)	4-W Change (%)	52-W Change (%)	YTD Change (%)	Beta	Short Ratio	P/E	P/S	P/B	10-Year P/E Range	10-Year P/S Range	10-Year P/B Range	PEG	1-Year Revenue Growth Rate	5-Year Revenue Growth Rate	10-Year Revenue Growth Rate	1-Year EBITDA Growth Rate	5-Year EBITDA Growth Rate	10-Year EBITDA Growth Rate	NCAV	Median PS Value	Graham Number	Peter Lynch Fair Value	Earnings Yield	Forward Rate of Return	Shiller P/E	EV/EBIT	EV/EBITDA	Predictability Rank	Operating Margin	Net Margin	Cash per Share	ROE	ROA	Altman Z Score	Piotroski F Score	Beneish M Score	EV/Sales
484640	TGTX	TGTX	5.65	-0.05 (-0.88%)	5.71	5.72	5.60	19K	03/12/2013	4.02	0	0%	40.55%	Add		TG Therapeutics Inc	OTCBB(USA)	Market Overview	150.039	0.06	0.6	0	0.00	0	53.8	26.4	0	1.82 6.75	1.99	-5.83	-8.87	55.22	0	0	0.00	1666.67	9.50		0.01 10	0.01 9.6	0	0	0	0	0	0	0	0.03	0	0	0	0.00	0	0	11.4	-17.74	Not Rated Top Ranked Predictable Companies	-141552.60	-95121.1	0.39	-116.2	-81.9	11.28	2	-1.66	201.44
483494	ALNY	ALNY	28.03	0.47 (1.71%)	27.56	28.23	27.38	212K	03/09/2013	24.47	0	0%	14.55%	Add	$ALNY: Focused on RNAi cooldecency99 (2 months ago)	Alnylam Pharmaceuticals, Inc.	NAS(USA)	Biotechnology	1713.43	64.78	2.17	0	0.00	0	65.4	20.7	10000	9.78 28.68	0.14	19.74	178.35	53.59	1.18	972	0.00	23.15	13.00		3.09 10	0.55 10	0	-36.1	-12.6	46.1	0	36.6	-5.6	-0.01	17.76	0	-34.39	0.00	17.13	0	9.7	-12.20	Not Rated Top Ranked Predictable Companies	-194.00	-158.9	-0.5	-79.1	-36.9	4.86	2	-3.66	3.64
483479	RXII	RXII	0.20	-	0.19	0.20	0.19	337K	03/09/2013	0.20	0	0%	0%	Add	$RXII: Focused on RNAi cooldecency99 (2 months ago)	RXi Pharmaceuticals Corp	OTCBB(USA)	Market Overview	67.6308	0.1	-0.0873	0	0.00	0	0	0	10000	0.05 0.3	2.3	-31.03	81.82	166.67	0	0	0.00	232.56	0.00		0 10		0	0	0	0	0	0	0	0.00	0	0	0	0.00	0	0	10.8	0.00	Not Rated Top Ranked Predictable Companies	-13376.30	-13278.4	0	0	-230.3	0	0	0	196.41
469197	ACHN	ACHN	7.75	0.20 (2.65%)	7.57	7.83	7.50	1.2M	02/16/2013	9.81	0	0%	-21%	Add	$ACHN: Focused on Hepa. cooldecency99 (2 months ago)	Achillion Pharmaceuticals, Inc.	NAS(USA)	Biotechnology	729.003	0.12	0.9	0	0.00	0	73.1	28.9	10000	5.42 11.36	6.16	4.73	7.49	-3.25	0.75	1138	0.00	5000.00	8.50	0 5.64	0.78 10	0.65 10	0	33.3	0	0	0	-16.9	0	0.01	5.03	0	0	286.70	-41.16	5.3	0.3	-28.91	Not Rated Top Ranked Predictable Companies	-1814.10	-1807.7	0.71	-65.4	-57.8	41.55	0	35.46	1203.18
469198	AGEN	AGEN	4.01	-0.13 (-3.14%)	4.11	4.16	4.00	149K	02/16/2013	4.35	0	0%	-7.82%	Add		Agenus, Inc.	NAS(USA)	Biotechnology	117.183	3.7	-0.92	-1.57	0.00	0	23.1	55.4	0	3.37 5.99	-8.86	-6.74	-28.39	-2.2	1.91	1041	0.00	26.39	0.00		4.61 10	0 10	0	-78.6	15.3	6.2	0	-45.5	-32.2	-0.04	6.69	0	0	670.10	-73.43	0	0.1	-7.79	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-42.20	-71	-1.21	0	-38.9	-34.82	1	14.92	-5.17
469199	BLRX	BLRX	1.75	-0.03 (-1.69%)	1.78	1.78	1.74	50.1K	02/16/2013	3.93	0	0%	-55.47%	Add		Bioline Rx Ltd.	NAS(USA)	Biotechnology	39.6146	0	0	0	0.00	0	0	0	0	1.59 5.1	-2.78	-4.37	-27.69	-30.83	0	39	0.00	0.00	0.00				0	0	0	0	0	0	0	0.00	0	0	0	0.00	0	0	250	0.00	Not Rated Top Ranked Predictable Companies	0.00	0	0	0	0	0	0	0	0
469200	IDIX	IDIX	4.07	0.01 (0.25%)	4.06	4.14	3.98	365K	02/16/2013	4.68	0	0%	-13.03%	Add		Idenix Pharmaceuticals, Inc.	NAS(USA)	Biotechnology	543.874	69.66	1.63	0.21	0.00	0	80.8	43	10000	3.21 11.3	11.51	7.11	-51.08	-16.08	0.33	1297	0.00	14.62	2.60	0 50	1.86 10	1.28 10	0	625	21.4	-24	0	-24.4	-5.1	0.02	8.04	0	0	0.00	-44.78	0	11.9	-9.82	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-50.80	-46.5	1.48	-14.8	-12.9	6.85	3	-3.16	2.95
469201	INO	INO	0.71	0.03 (4.35%)	0.67	0.72	0.67	2.7M	02/16/2013	0.73	0	0%	-2.74%	Add		Inovio Pharmaceuticals, Inc.	AMEX(USA)	Biotechnology	122	3.88	0.19	0	0.00	0	52.3	29.8	10000	0.38 0.83	7.2	25.22	54.48	41.64	2.71	95	0.00	25.84	3.80		1.51 10	0.38 10	0	-50	-13.3	1.4	0	-11.2	-16.2	0.00	0.35	0	0	0.00	-35.91	0	0.2	-3.82	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-570.40	-477.5	0.02	-57.3	-43.6	-1.95	0	0.22	7.23
469202	LGND	LGND	27.74	0.17 (0.62%)	27.66	27.92	27.55	123K	02/16/2013	21.96	0	0%	26.32%	Add		Ligand Pharmaceuticals, Inc.	NAS(USA)	Drug Manufacturers - Specialty & Generic	557.878	37.4	1.31	3.5	0.00	0	30.8	54.5	0.2	11.28 29.92	3.74	3.05	136.09	33.75	1.15	1442	2540.50	14.81	21.30	0.95 50	2.23 10	3.72 10	0	15.5	-4.6	-26.1	115.8	0	0	0.21	15.38	0	0	0.90	-3.64	12.6	111.1	70.31	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	1.80	-1.7	-3.23	-2	-0.5	-4.85	7	-2.58	-0.58
469203	MDGN	MDGN	4.15	-0.03 (-0.72%)	4.20	4.23	4.08	4.5K	02/16/2013	5.06	0	0%	-17.98%	Add		Medgenics Inc	AMEX(USA)	Biotechnology	77.2519	0	0	0	0.00	0	0	0	0	3.66 16.43	-3.71	3.75	-26.94	-44.22	0	806	0.00	0.00	0.00				0	0	0	0	0	0	0	0.00	0	0	0	0.00	0	0	21.7	0.00	Not Rated Top Ranked Predictable Companies	0.00	0	0	0	0	0	0	0	0
469204	SCLN	SCLN	4.87	0.02 (0.41%)	4.84	4.89	4.73	91.5K	02/16/2013	4.97	0	0%	-2.01%	Add		SciClone Pharmaceuticals	NAS(USA)	Drug Manufacturers - Specialty & Generic	262.277	156.27	2.65	0	0.00	0	80.8	52.9	66.8	3.68 7.58	-1.81	8.95	-18.43	13	1.45	1177	30.40	1.82	1.80	6.32 50	0.67 10	0.82 10	0	16.9	23	18.8	-71.4	0	0	0.64	10	2.62	0	3.50	2.97	29.5	28.6	18.86	Currently 1/5 Business Predictability Rank: 1-Star (On Watch) Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	4.10	6.2	0.99	6.7	5.5	5.86	5	-4.12	0.53
469205	SGEN	SGEN	35.73	-0.02 (-0.06%)	35.78	36.20	35.50	450K	02/16/2013	27.44	0	0%	30.21%	Add		Seattle Genetics, Inc.	NAS(USA)	Biotechnology	4335.25	219.9	1.88	0	0.00	0	88.5	38	10000	19.03 39	-7.34	-3.33	66.73	54.21	1.02	2408	0.00	19.31	19.10		9.98 10	1.61 10	0	66.1	37	29.9	0	-14.4	-0.7	0.38	48.26	0	0	0.00	-11	0	11.5	-78.46	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-27.20	-25.5	0.99	-23.8	-11.4	10.46	3	-4.1	1.56
469206	SPPI	SPPI	8.13	0.08 (0.98%)	8.07	8.16	8.03	664K	02/16/2013	11.68	0	0%	-30.39%	Add		Spectrum Pharmaceuticals Inc	NAS(USA)	Biotechnology	483.276	246.52	4.74	0	0.00	0	75.8	51.2	0	6.92 17.48	0.87	13.55	-27.56	-27.32	1.43	1222	11.35	2.08	1.70	7.25 50	0.67 10	0.54 10	0	12.8	53.2	69	-10.1	0	0	1.25	28.01	5.22	0	13.00	-0.43	0	7.7	6.33	Currently 1/5 Business Predictability Rank: 1-Star (On Watch) Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	29.80	35.3	-1.3	33.2	18.7	2.1	4	-2.53	0.33
469207	SRPT	SRPT	36.65	-0.48 (-1.29%)	37.01	37.41	35.27	1M	02/16/2013	26.31	0	0%	39.3%	Add	$SRPT: Focused on orphan drugs for Duchenne muscular dystrophy (DMD). JUst reported solid trial result for phase 11b drug candidate Etepirsen cooldecency99 (3 months ago)	Sarepta Therapeutics Inc	NAS(USA)	Market Overview	1184.8	30.59	3.89	0	0.00	0	61.2	38	10000	3.3 45	4.36	11.53	809.39	42.05	0	391	0.00	31.06	9.40		1.56 10	1.61 10	0	-34.2	3.6	45.5	0	-6.8	-13.4	0.25	69.26	0	0	0.00	-11.14	0	7.3	-26.40	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-79.60	-324.9	3.34	-98.1	-59.2	2.88	3	-4.28	5.43
469209	THRX	THRX	37.52	0.51 (1.38%)	37.14	38.17	37.00	1.3M	02/16/2013	22.17	0	0%	69.24%	Add		Theravance, Inc.	NAS(USA)	Biotechnology	3680.78	10	1.58	-1.98	0.00	0	53.8	42.1	0	17.06 42.41	-10.39	17.51	80.3	68.71	1.43	1408	0.00	357.14	23.60			5.66 10	0	-93.1	28	7.9	0	-46.5	-30.6	0.05	6.91	0	0	0.00	-42.93	0	16.9	-31.44	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-9.60	-13.7	0.37	-12	-5	2.15	3	222.93	-0.09
461840	GILD	GILD	56.47	0.73 (1.31%)	56.14	56.85	55.76	10.1M	02/03/2013	40.56	0	0%	39.23%	Add		Gilead Sciences Inc	NAS(USA)	Biotechnology	85023.3	9951.7	6.11	1.13	0.00	0	58.1	69.4	11.1	24.12 57.1	0.39	6.21	121.93	53.76	0.45	507	31.65	9.13	9.10	9.71 50	3.48 10	4.15 10	1.9	10	21.3	32.1	9.8	16.3	0	1.43	70.54	0	31.03	4.70	19.77	37.3	21.3	19.93	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	41.30	26.7	-6.61	27.8	12.2	5.54	7	-2.86	-0.63
134810	CYTX	CYTX	2.54	0.04 (1.60%)	2.51	2.58	2.50	207K	05/01/2010	5.64	0	0%	-54.96%	Add	Conducting trial for its breast reconstruction technique. cooldecency99 (3 years ago)	Cytori Therapeutics, Inc.	NAS(USA)	Biotechnology	167.958	16.78	0.1	2.21	0.00	0	30.8	43	0	2.04 4.93	-9.29	2.42	18.14	-9.29	1.92	2577	0.00	9.24	26.50	0 50	5.74 10	2.93 10	0	107.7	-2.3	-13.5	0	-15	-9	0.06	4.75	0	0	0.00	-41.26	0	2.1	-7.07	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-196.00	-222.6	-0.17	-500.1	-74.6	-9.09	3	-2.26	-0.29
134809	EXAS	EXAS	10.76	0.14 (1.32%)	10.64	10.97	10.60	824K	05/01/2010	4.44	0	0%	142.34%	Add	Facing decision on the result of independent (Mayo Clinic) test of its colon cancer prep pack by 4th quarter. cooldecency99 (3 years ago)	Exact Sciences Corporation	NAS(USA)	Biotechnology	680.691	4.14	1.54	0.01	0.00	0	65.4	26.4	10000	6.93 12.3	4.98	16.58	5.91	1.61	1.36	879	0.00	158.73	6.90	0 21.2	8.84 10	1.49 10	0	0	0	0	0	28.9	-6	0.03	3.02	0	-21.5	0.00	22.91	0	1000	-11.60	Currently 1/5 Business Predictability Rank: 1-Star Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	-1270.30	-1265	1.48	-53.2	-46.8	34.61	3	0	22.59
134805	KERX	KERX	8.05	0.11 (1.39%)	7.99	8.20	7.87	1.4M	05/01/2010	5.59	0	0%	44.01%	Add	In 2010 reported positive phase 2 trial result for its cancer drug candidate. cooldecency99 (3 years ago)	Keryx Biopharmaceuticals, Inc.	NAS(USA)	Drug Manufacturers - Specialty & Generic	648.841	7	0.46	0	0.00	0	0	0	10000	1.55 9.98	-4.96	0.25	352.25	207.25	0	261	0.00	84.03	17.50	0 23.71	1.1 10	1.87 10	0	520	103.6	0	0	0	0	0.01	3.34	0	0	0.00	-9.7	0	7	-263.69	Not Rated Top Ranked Predictable Companies	-575.00	-562.5	0.4	-90.6	-64.7	40.98	5	-3.51	12.48
134806	PCYC	PCYC	84.71	2.85 (3.48%)	81.50	85.47	81.50	767K	05/01/2010	7.59	0	0%	1016.07%	Add	In 2010 reported positive phase 2 trail result for its cancer drug candidate. cooldecency99 (3 years ago)	Pharmacyclics, Inc.	NAS(USA)	Drug Manufacturers - Specialty & Generic	5958.02	184.65	1.87	0	0.00	0	92.3	63.6	10000	28.77 95.85	-3.89	9.28	170.81	46.61	1.06	327	61.35	34.01	45.30	35.9 50		0.26 10	0	29.8	235.1	18.1	-153.1	0	0	0.08	84.46	2.6	0	0.10	-0.67	0	1000	611.60	Currently 1/5 Business Predictability Rank: 1-Star (On Watch) Back Testing Results: Average gain of all 1-Star stocks: 1.1% per year. % of Stocks that are in still loss if held for 10yrs: 45%. Read more: What is Predictability Rank? Performances of real portfolio Top Ranked Predictable Companies	14.50	14.6	1.66	9.1	5.5	34.27	3	16.47	2.77
134808	ONTY	ONTY	2.00	-	2.02	2.05	1.98	1.3M	05/01/2010	4.04	0	0%	-50.5%	Add	Facing decision on the result of its stage 3 trial cancer drug from partner Marck-Kgaa by 4th quarter. cooldecency99 (3 years ago)	Oncothyreon, Inc.	NAS(USA)	Biotechnology	114.432	0	0	0	0.00	0	0	0	0	1.71 6.24	-21.26	-17.01	-42.69	4.17	0	1481	0.00	0.00	0.00				0	0	0	0	0	0	0	0.00	0	0	0	0.00	0	0	0.4	0.00	Not Rated Top Ranked Predictable Companies	0.00	0	0	0	0	0	0	0	0
		Summary		0.22 (0.65%)									57.42%																						127.39	367.17	10.46	127.39	367.17	10.46

Add this list into my watchlist/portfolio:

Portfolio's Discussions:

cooldecency99 3 years ago

Biotech stocks to watch
Write a comment ...

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles

cooldecency99 Portfolios

Emerging-Biotech Open to everyone

Add this list into my watchlist/portfolio:

Portfolio's Discussions: